Harm reduction
33 articles
Time for Change: Advancing New Drug Policies That Uphold Human Rights
To mark the Global Day of Action, 26 June, of the Support. Don’t Punish campaign, Amnesty International releases a policy paper to contribute to the advancement of drug policies that better uphold human rights. More
Creating Safer Consumption Spaces in Europe: Evolving Contexts and Implications for Policy
C-EHRN releases a policy brief providing an overview of the state of the art regarding Drug Consumption Rooms, as well as an overview of recommendations and examples of good practices for policymakers. More
Integration of Hepatitis C Testing and Treatment in OAT Clinics in Canada
Findings from a study suggest that OAT programs are ideally positioned to reach people who previously injected or currently inject drugs to engage them in hepatitis C testing and treatment. More
A Framework for Approaching Hepatitis C Reinfection in People Who Use Drugs
A review, published in Clinical Liver Disease, summarizes HCV reinfection incidence and outcomes among PWIDs and describes a multifaceted approach to addressing HCV reinfection among PWIDs. More
Hepatitis C Reinfection Common Among Treated PWID
Among PWID treated for hepatitis C, rates of reinfection were high soon after sustained virologic response but decreased with longer follow-up, according to a secondary analysis of the randomized HERO trial. More
